Market Research

North America Penicillin Drug Market Size, Share & Industry Trends Analysis Report By Source (Semisynthetic Penicillin and Natural Penicillin), By Spectrum of Activity, By Distribution Channel, By Route of Administration, By Country and Growth Forecast,

Best Price Guarantee Length Publisher Published Date SKU
from $1,500 132 Pages Knowledge Based Value (KBV) Research July, 2023 KBV18138547
Best Price Guarantee
Price from $1,500
Length 132 Pages
Publisher Knowledge Based Value (KBV) Research
Published Date July, 2023
SKU KBV18138547

North America Penicillin Drug Market Size, Share & Industry Trends Analysis Report By Source (Semisynthetic Penicillin and Natural Penicillin), By Spectrum of Activity, By Distribution Channel, By Route of Administration, By Country and Growth Forecast, 2023 - 2030


The North America Penicillin Drug Market would witness market growth of 2.7% CAGR during the forecast period (2023-2030).

Skin infections, tooth infections, ear infections, nose, throat, or lungs infections, urinary tract infections, and other bacterial diseases are all common health concerns worldwide. The bacteria Streptococcus pneumonia, Listeria, Neisseria gonorrhea, Clostridium, Peptococcus, and Peptostreptococcus belong to the organisms that penicillin is effective against.

The enormous prevalence of pneumonia and other respiratory tract illnesses is a factor in the market's expansion. Since penicillin is an established and reliable antibiotic, it continues to be the first line of treatment for many bacterial illnesses. The increasing prevalence of these illnesses in both public and medical settings necessitate the use of penicillin and fuels the expansion of the market.

Additionally, improvements in healthcare infrastructure and accessibility to healthcare services greatly impact the market share. The identification and treatment of bacterial infections have improved due to improving healthcare infrastructure, particularly in developing nations. The availability and accessibility of penicillin are improved as healthcare systems grow, resulting in higher consumption and market expansion.

The American Cancer Society reports that in 2018, there were roughly 154,050 lung cancer-related deaths in the United States, with an estimated 234,030 new cases of lung cancer being diagnosed. 541,000 Americans have been given a lung cancer diagnosis at some point in their lives, according to the American Lung Association. Many patients have received a lung cancer diagnosis during the last five years. Each year, non-small cell lung cancer (NSCLC) is treated in tens of thousands of Americans. Additionally, chronic diseases are becoming more common in the region. Because of the increase in cancer incidence, there is a greater need for products such as penicillin drugs, which boosts the regional market.

The US market dominated the North America Penicillin Drug Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $2.1 billion by 2030. The Canada market is poised to grow at a CAGR of 5% during (2023 - 2030). Additionally, The Mexico market would witness a CAGR of 4.1% during (2023 - 2030).

Based on Source, the market is segmented into Semisynthetic Penicillin and Natural Penicillin. Based on Spectrum of Activity, the market is segmented into Broad spectrum, Extended spectrum and Narrow spectrum. Based on Distribution Channel, the market is segmented into Drug Stores & Retail Pharmacies, Hospital Pharmacies and Online Providers. Based on Route of Administration, the market is segmented into Parenteral and Oral. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include GlaxoSmithKline PLC (GSK), Pfizer, Inc., Novartis AG, Lupin Limited, Abbott Laboratories, Cipla Limited, Takeda Pharmaceutical Company Limited, Alkem Laboratories Ltd., Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Ltd.

Scope of the Study

Market Segments covered in the Report:

By Source
  • Semisynthetic Penicillin
  • Natural Penicillin
By Spectrum of Activity
  • Broad spectrum
  • Extended spectrum
  • Narrow spectrum
By Distribution Channel
  • Drug Stores & Retail Pharmacies
  • Hospital Pharmacies
  • Online Providers
By Route of Administration
  • Parenteral
  • Oral
By Country
  • US
  • Canada
  • Mexico
  • Rest of North America
Companies Profiled
  • GlaxoSmithKline PLC (GSK)
  • Pfizer, Inc.
  • Novartis AG
  • Lupin Limited
  • Abbott Laboratories
  • Cipla Limited
  • Takeda Pharmaceutical Company Limited
  • Alkem Laboratories Ltd.
  • Teva Pharmaceuticals Industries Ltd.
  • Sun Pharmaceutical Industries Ltd.
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Penicillin Drug Market, by Source
1.4.2 North America Penicillin Drug Market, by Spectrum of Activity
1.4.3 North America Penicillin Drug Market, by Distribution Channel
1.4.4 North America Penicillin Drug Market, by Route of Administration
1.4.5 North America Penicillin Drug Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.2.4 Trials and Approvals
4.3 Top Winning Strategies
4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
4.3.2 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2020, Jun – 2023, Mar) Leading Players
4.4 Porter Five Forces Analysis
Chapter 5. North America Penicillin Drug Market by Source
5.1 North America Semisynthetic Penicillin Market by Country
5.2 North America Natural Penicillin Market by Country
Chapter 6. North America Penicillin Drug Market by Spectrum of Activity
6.1 North America Broad spectrum Market by Country
6.2 North America Extended spectrum Market by Country
6.3 North America Narrow spectrum Market by Country
Chapter 7. North America Penicillin Drug Market by Distribution Channel
7.1 North America Drug Stores & Retail Pharmacies Market by Country
7.2 North America Hospital Pharmacies Market by Country
7.3 North America Online Providers Market by Country
Chapter 8. North America Penicillin Drug Market by Route of Administration
8.1 North America Parenteral Market by Country
8.2 North America Oral Market by Country
Chapter 9. North America Penicillin Drug Market by Country
9.1 US Penicillin Drug Market
9.1.1 US Penicillin Drug Market by Source
9.1.2 US Penicillin Drug Market by Spectrum of Activity
9.1.3 US Penicillin Drug Market by Distribution Channel
9.1.4 US Penicillin Drug Market by Route of Administration
9.2 Canada Penicillin Drug Market
9.2.1 Canada Penicillin Drug Market by Source
9.2.2 Canada Penicillin Drug Market by Spectrum of Activity
9.2.3 Canada Penicillin Drug Market by Distribution Channel
9.2.4 Canada Penicillin Drug Market by Route of Administration
9.3 Mexico Penicillin Drug Market
9.3.1 Mexico Penicillin Drug Market by Source
9.3.2 Mexico Penicillin Drug Market by Spectrum of Activity
9.3.3 Mexico Penicillin Drug Market by Distribution Channel
9.3.4 Mexico Penicillin Drug Market by Route of Administration
9.4 Rest of North America Penicillin Drug Market
9.4.1 Rest of North America Penicillin Drug Market by Source
9.4.2 Rest of North America Penicillin Drug Market by Spectrum of Activity
9.4.3 Rest of North America Penicillin Drug Market by Distribution Channel
9.4.4 Rest of North America Penicillin Drug Market by Route of Administration
Chapter 10. Company Profiles
10.1 Novartis AG
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expense
10.1.5 Recent strategies and developments:
10.1.5.1 Partnerships, Collaborations, and Agreements:
10.1.5.2 Acquisition and Mergers:
10.1.6 SWOT Analysis
10.2 Teva Pharmaceutical Industries Ltd.
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Regional Analysis
10.2.4 Research & Development Expenses
10.2.5 SWOT Analysis
10.3 Sun Pharmaceutical Industries Ltd.
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Regional Analysis
10.3.4 Research & Development Expenses
10.3.5 Recent strategies and developments:
10.3.5.1 Acquisition and Mergers:
10.3.6 SWOT Analysis
10.4 GlaxoSmithKline PLC (GSK)
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Regional Analysis
10.4.4 Research & Development Expense
10.4.5 Recent strategies and developments:
10.4.5.1 Partnerships, Collaborations, and Agreements:
10.4.6 SWOT Analysis
10.5 Pfizer, Inc.
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Regional & Segmental Analysis
10.5.4 Research & Development Expense
10.5.5 Recent strategies and developments:
10.5.5.1 Partnerships, Collaborations, and Agreements:
10.5.5.2 Acquisition and Mergers:
10.5.5.3 Trials and Approvals:
10.5.6 SWOT Analysis
10.6 Lupin Limited
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Recent strategies and developments:
10.6.3.1 Partnerships, Collaborations, and Agreements:
10.6.4 SWOT Analysis
10.7 Abbott Laboratories
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Segmental and Regional Analysis
10.7.4 Research & Development Expense
10.7.5 SWOT Analysis
10.8 Cipla Limited
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Regional Analysis
10.8.4 Research & Development Expense
10.8.5 Recent strategies and developments:
10.8.5.1 Partnerships, Collaborations, and Agreements:
10.8.5.2 Acquisition and Mergers:
10.8.6 SWOT Analysis
10.9 Alkem Laboratories Ltd.
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Regional Analysis
10.9.4 Research & Development Expenses
10.9.5 Recent strategies and developments:
10.9.5.1 Product Launches and Product Expansions:
10.9.6 SWOT Analysis
10.10. Takeda Pharmaceutical Company Limited
10.10.1 Company Overview
10.10.2 Financial Analysis
10.10.3 Regional Analysis
10.10.4 Research & Development Expense
10.10.5 Recent strategies and developments:
10.10.5.1 Acquisition and Mergers:
10.10.6 SWOT Analysis

$1,500
$1,800
$2,520

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings